✦ LIBER ✦

Assessment of a formulation designed to be crush-resistant in prescription opioid abusers

✍ Scribed by Suzanne K. Vosburg; Jermaine D. Jones; Jeanne M. Manubay; Judy B. Ashworth; Irma H. Benedek; Sandra D. Comer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparison among tapentadol tamper-res

✍ Vosburg, Suzanne K.; Jones, Jermaine D.; Manubay, Jeanne M.; Ashworth, Judy B.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

The impact of a reformulation of extende

✍ Havens, Jennifer R.; Leukefeld, Carl G.; DeVeaugh-Geiss, Angela M.; Coplan, Paul 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 517 KB

A systematic literature review of the ef

✍ E. Michna; W. Cheng; C. Korves; S. Sarda; D. Schaaf; R. Andrews; Z. Zhou; J. Mar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Effects of the NK1 antagonist, aprepitan

✍ Sharon L. Walsh; Markus Heilig; Paul A. Nuzzo; Pam Henderson; Michelle R. Lofwal 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

A meta-analysis of efficacy and safety o

✍ Michna, E.; Cheng, W.; Korves, C.; Schaaf, D.; Andrews, R.; Zhou, Z.; Mardekian, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

A primary care-based, open-label study a

✍ Setnik, B.; Roland, C.; Sommerville, K.; Goli, V.; Pixton, G.; Berke, R.; Calkin 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 92 KB